Virology & Vaccines
Data & insights throughout the product lifecycle
The COVID-19 pandemic reinforced the ever-present threat of viral diseases, and the importance of vaccines and antivirals in managing them…
Led by our experts in virology and vaccines, Ipsos partners with clients manufacturing and developing products in this space – offering incisive insights and market-sensitive recommendations.
Tailored insights & guidance
Our custom research insights, market access/HEOR solutions and advisory services guide many of today’s leading pharma and MD&D clients through this fast-moving, high-profile arena.
Global Healthcare Monitors (multi-client data)
We also run expert-led multi-stakeholder perceptual monitors in vaccines (COVID-19, Flu & RSV) and COVID-19 diagnostics & treatments, while Ipsos Global Therapy Monitors capture real-world prescribing data, layered with HCP perceptions, in specific viral diseases.
Recent thought leadership
PoV: The Impact of COVID-19 on the Mental Health of our Youth
PoV: RSV: The Race to Market Continues
Paper: Vaccine hesitancy: Understanding Belief Formation
Talk to us about your virology & vaccines business questions.
